These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35524443)

  • 1. Efficacy of autologous platelet-rich plasma in the treatment of vitiligo: A 10-patient prospective study.
    Rekik M; Mseddi M; Kammoun N; Sellami K; Turki H
    J Cosmet Dermatol; 2022 Oct; 21(10):4225-4233. PubMed ID: 35524443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: A prospective, randomized comparative trial.
    Abdelghani R; Ahmed NA; Darwish HM
    J Cosmet Dermatol; 2018 Jun; 17(3):365-372. PubMed ID: 28834191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-cultured epidermal cells suspended in either platelet-rich plasma or ringer lactate for stable vitiligo: A prospective comparative study.
    Albalat W; Elsayed M; Salem A; Ehab R; Fawzy M
    J Cosmet Dermatol; 2022 Jul; 21(7):3102-3109. PubMed ID: 34706162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of platelet-rich plasma to suspend noncultured epidermal cell suspension improves repigmentation after autologous transplantation in stable vitiligo: a double-blind randomized controlled trial.
    Parambath N; Sharma VK; Parihar AS; Sahni K; Gupta S
    Int J Dermatol; 2019 Apr; 58(4):472-476. PubMed ID: 30506679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of adding platelet-rich plasma (PRP) to noncultured epidermal cell suspension (NCECS) in surgical treatment of stable resistant vitiligo: A self-controlled randomised double-blinded study.
    Abdel Halim DM; Fekry A; Mogawer RM
    Australas J Dermatol; 2023 Aug; 64(3):359-367. PubMed ID: 37228170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-arm open-label clinical trial of autologous epidermal cell transplantation for stable vitiligo: A 30-month follow-up.
    Orouji Z; Bajouri A; Ghasemi M; Mohammadi P; Fallah N; Shahbazi A; Rezvani M; Vaezirad F; Khalajasadi Z; Alizadeh A; Taghiabadi E; Dashtbozorgi S; Aghdami R; Hosseini SE; Bahahrvand H; Shafieyan S; Aghdami N
    J Dermatol Sci; 2018 Jan; 89(1):52-59. PubMed ID: 29103774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of fractional erbium-YAG laser, microneedling, platelet-rich plasma in localized stable vitiligo patients: randomized clinical trial.
    Abdel-Hamid S; Ibrahim HM; Hameed AM; Hegazy EM
    Arch Dermatol Res; 2024 Jun; 316(7):399. PubMed ID: 38878236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser Ablation of the Recipient Area With Platelet-Rich Plasma-Enriched Epidermal Suspension Transplant in Vitiligo Surgery: A Pilot Study.
    Garg S; Dosapaty N; Arora AK
    Dermatol Surg; 2019 Jan; 45(1):83-89. PubMed ID: 30188329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of combined excimer laser and platelet-rich plasma for the treatment of nonsegmental vitiligo: A prospective comparative study.
    Khattab FM; Abdelbary E; Fawzi M
    J Cosmet Dermatol; 2020 Apr; 19(4):869-877. PubMed ID: 31541597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot Study on the Use of the "Monocyte-Rich" Platelet-Rich Plasma in Combination with 1927 nm Fractional and 308 nm Excimer Lasers for the Treatment of Vitiligo.
    Mercuri SR; Di Nicola MR; Brianti P; Bianchi VG; Paolino G
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577827
    [No Abstract]   [Full Text] [Related]  

  • 12. Current art of combination therapy with autologous platelet-rich plasma for stable vitiligo: A meta-analysis.
    Chen J; Wan Y; Lin Y; Jiang H
    Int Wound J; 2021 Jun; 18(3):251-260. PubMed ID: 33245822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of efficacy of noncultured hair follicle cell suspension and noncultured epidermal cell suspension in repigmentation of leukotrichia and skin patch in vitiligo: a randomized trial.
    Gunaabalaji DR; Pangti R; Challa A; Chauhan S; Sahni K; Arava SK; Sethuraman G; Vishnubhatla S; Sharma VK; Gupta S
    Int J Dermatol; 2020 Nov; 59(11):1393-1400. PubMed ID: 32989783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Follicular and Epidermal Cell Suspension as a Novel Surgical Approach in Difficult-to-Treat Vitiligo: A Randomized Clinical Trial.
    Razmi T M; Kumar R; Rani S; Kumaran SM; Tanwar S; Parsad D
    JAMA Dermatol; 2018 Mar; 154(3):301-308. PubMed ID: 29387874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical efficacy of treatment using the autologous non-cultured epidermal cell suspension technique for stable vitiligo in 41 patients.
    Liu B; Chen HH; Liu ZH; Liang JF; Xue RJ; Chen PJ; Li CX; Liang XD; Deng J; Ye RX; Zhang XB; Liang JY
    J Dermatolog Treat; 2021 Feb; 32(1):90-94. PubMed ID: 31084382
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of autologous micrografts on stable bilateral vitiligo: A focus on hand lesions.
    Menchini G; Astarita C
    J Dermatol; 2020 Dec; 47(12):1417-1423. PubMed ID: 32954507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo.
    van Geel N; Ongenae K; De Mil M; Haeghen YV; Vervaet C; Naeyaert JM
    Arch Dermatol; 2004 Oct; 140(10):1203-8. PubMed ID: 15492182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas.
    Silpa-Archa N; Griffith JL; Huggins RH; Henderson MD; Kerr HA; Jacobsen G; Mulekar SV; Lim HW; Hamzavi IH
    J Am Acad Dermatol; 2017 Aug; 77(2):318-327. PubMed ID: 28502377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and treatment characteristics determining therapeutic outcome in patients undergoing autologous non-cultured outer root sheath hair follicle cell suspension for treatment of stable vitiligo.
    Vinay K; Dogra S; Parsad D; Kanwar AJ; Kumar R; Minz RW; Saikia UN
    J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):31-7. PubMed ID: 24628828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of clinical efficacy and psychosocial impact on vitiligo patients by excimer laser treatment.
    Al-Shobaili HA
    Ann Saudi Med; 2014; 34(2):115-21. PubMed ID: 24894779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.